This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
LYC Mother & Child Centre Sdn Bhd agreed to acquire 49% stake in LYC SOG Mother & Child Sdn Bhd from Singapore O&G Ltd. for MYR 4.5 million. CI
Singapore O&G Delists from Bourse as NewMedCo Completes Acquisition of Dissenting Shareholders' Shares MT
Singapore O&G to Delist from Singapore Exchange on June 17 MT
Singapore O&G Gets Regulatory Nod to Delist from Bourse MT
Singapore O&G Sets Up New Subsidiary in Singapore MT
Singapore O&G Ltd. Announces Incorporation of New Subsidiary CI
Hanaan Health Group Ltd., Beh Suan Tiong, Heng Tung Lan, Lee Keen Whye, Joyce Lim Teng Ee and Choo Wan Ling completed the acquisition of Singapore O&G Ltd. from Heng Siok Hong Veronica, Wong Chui Fong, Anna, Lee Tian Loon, Lee Tian Yang, Lee Tian Mun, Lee Wen Yi, Lee Wai Chan, Choo Wan Mei and Kessler Investment Holding Limited. CI
NewMedCo Extends Closing Date of Offer to Acquire Singapore O&G MT
NewMedCo's Ownership in Singapore O&G Reaches Nearly 88% MT
Singapore O&G Issues Shares Under Performance Share Plan MT
NewMedCo's Ownership in Singapore O&G Reaches Nearly 81% MT
Hanaan Health Group Ltd., Beh Suan Tiong, Heng Tung Lan, Lee Keen Whye, Joyce Lim Teng Ee and Choo Wan Ling made an offer to acquire Singapore O&G Ltd. from Heng Siok Hong Veronica, Wong Chui Fong, Anna, Lee Tian Loon, Lee Tian Yang, Lee Tian Mun, Lee Wen Yi, Lee Wai Chan, Choo Wan Mei and Kessler Investment Holding Limited for approximately SGD 140 million. CI
Singapore O&G Receives Voluntary Takeover Offer from Sponsor, Promoters MT
Singapore O&G Ltd. Announces Executive Changes CI
Singapore Shares End in Red; Singapore O&G Plummets 11% on 33% Drop in H2 2021 Profit MT
Singapore O&G's H2 2021 Profit Plummets 32.5%; Shares Slip 9% MT
Singapore O&G Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Singapore O&G Ltd. Announces Resignation of Lee Keen Whye as Executive Director CI
Singapore O&G : Joint Venture Establishes Marketing Unit MT
Singapore O&G Ltd. Announces Executive Director Dr. Lee Keen Extends Medical Leave of Absence CI
Singapore O&G : Logs Higher Profit, Revenue in H1 on Increased Patient Load MT
Tranche Update on Singapore O&G Ltd.'s Equity Buyback Plan announced on June 9, 2020. CI
Singapore O&G Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Singapore O&G Ltd. Announces Cessation of Chooi Yee-Choong from Non-Executive Independent Director, Chairman of Remuneration Committee and Member of Nominating Committee CI
Singapore O&G Ltd. Announces Appointment of Ms. Linda Hoon Siew Kin as Independent Director, Chairman of Nominating Committee, and Member of Audit Committee and Remuneration Committee CI
Chart Singapore O&G Ltd.
More charts
Singapore O&G Ltd. is a Singapore-based healthcare service provider. The Company is engaged in delivering medical services to women's and children's health and wellness. The Company operates through four segments: Obstetrics and Gynaecology (O&G), Cancer-related, Dermatology and Paediatrics. Its O&G segment relates to general obstetrics, labor and delivery, general gynecology and surgery, female pelvic medicine, urogynecology and reconstructive surgery. Its Cancer-related segment relates to medical services for gynae-oncology, breast and general surgery. Its Dermatology segment relates to the provision of aesthetic dermatological procedures, dermatologic and laser surgery and general skin care. Its Paediatrics segment relates to the provision of general pediatrics and adolescent medical services.
More about the company
  1. Stock Market
  2. Equities
  3. 1D8 Stock
  4. News Singapore O&G Ltd.
  5. Singapore O&G Gets Regulatory Nod to Delist from Bourse